REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/06/2026
Back to search
Official data from USPTO
Q
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000087392124Class
1, 5, 9, 10, 42, 44
Filing
87392124
Registration
6406039
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
66
Latest update
07/06/2026
Trademark type
Combined
Nice classes
1, 5, 9, 10, 42, 44
Filing date
03/30/2017
Registration date
07/06/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/06/2021
Last transaction
07/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
3
Owner type
11
Owner location
Uppsala, SE
Examiner
MAYES, LAURIE ANN
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the letter "Q" in a circular design in the color orange, with split openings creating the circle and a larger point at the right end. The color orange is a part of the mark. The color white is not claimed as a feature of the mark but merely represents background.
Holders and representatives
Holders
Q-linea AB
Representatives
Donna J. Bunton NIXON & VANDERHYE P.C.
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic preparations for scientific or research use; diagnostic reagents for scientific or research use; biochemicalsmonoclonal antibodies for in vitro scientific or research use; reagents for use in scientific apparatus for chemical or biological analysis; chemical preparations for scientific purposesother than for medical or veterinary use; diagnostic preparations for scientific or research use other than for medical use; nucleic acids for laboratory use; nucleic acid for use in nucleic acid amplification processes other than for medical and veterinary use; nucleic acid amplification reagents other than for medical and veterinary use; nucleic acid sequencing programs other than for medical and veterinary use; nucleic acid sequencesother than for medical or veterinary purposes; chemicals for use in multiplying nucleic acid amounts other than medical and veterinary use; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria; diagnostic preparations for scientific purposes; chemical products for scientific diagnostic use; chemical diagnostic reagents for industrial use; diagnostic preparationsother than for medical or veterinary purposes
Class 5
Nucleic acid sequences for medical and veterinary purposes; diagnostic preparations for veterinary purposes; medical diagnostic reagents; clinical diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical purposes
Class 9
Scientific apparatus for detectingidentifying and analyzing pathogens and infectious agentsfor microbial identification and antibiotic resistance marker mappingall the aforesaidfor laboratory or medical research purposes; Scientific instruments for microbial identification and antibiotic resistance marker mapping; laboratory instruments for the detection of pathogens and toxins in a biological sample for research use; diagnostic apparatusnot for medical purposesfor the detection and identification of pathogens for laboratory or research purposes; software for use in protein and nucleic acid analysismicro-organism detection and identificationin vitro diagnostics; computer operating systems; detection apparatusmedical laboratory research apparatus for detecting pathogens or infectious agents; diagnostic apparatusfluorescence detectors; measuring instruments for measuring and quantifying DNA sequences; measuring apparatus for measuring and quantifying DNA sequences; testing apparatus for diagnostic purposes other than medical and veterinary useapparatus for testing antibiotic susceptibility of pathogens
Class 10
Diagnostic apparatus for the detection of abnormal prion protein for medical use for the detection of cancer; medical apparatustesting apparatus for analyzing bacteria in biological samples for medical use; medical diagnostic instruments for the detection and identification of pathogens or infectious agents; diagnostic apparatus for the detection and identification of pathogens or infectious agents for medical use; testing instruments for medical diagnostic purposesfor testing blood and other bodily fluids and biological samples; testing apparatus for testing blood and other bodily fluids and biological samples for medical and veterinary use
Class 42
Scientific analysis in the field of molecular biology; scientific research relating to molecular sciences; technological scientific research relating to protein and nucleic acid analysismicro-organism detection and identificationin vitro diagnosticsthe detectionidentification and analysis of pathogens and infectious agentsthe antibiotic susceptibility of pathogensmicrobial identification and antibiotic resistance marker mapping; technological scientific studies relating to protein and nucleic acid analysismicro-organism detection and identificationin vitro diagnosticsthe detectionidentification and analysis of pathogens and infectious agentsthe antibiotic susceptibility of pathogensmicrobial identification and antibiotic resistance marker mapping; technological scientific consultancy relating to protein and nucleic acid analysismicro-organism detection and identificationin vitro diagnosticsthe detectionidentification and analysis of pathogens and infectious agentsthe antibiotic susceptibility of pathogensmicrobial identification and antibiotic resistance marker mapping; scientific and scientific technological servicesprotein and nucleic acid analysismicro-organism detection and identificationin vitro diagnosticsthe detectionidentification and analysis of pathogens and infectious agentsanalyzing and testing the antibiotic susceptibility of pathogensmicrobial identificationantibiotic resistance marker mapping; scientific consultancy and research services in the fields of scienceengineering and information technology; provision of scientific information and data relating to scientific and technological research and development; research and development services in the field of bacteriologycytologyantibody technologychemistryimmunology and gene expression systems; scientific research; scientific consultancy relating to dietary supplements; scientific analysis in the field of molecular biology; scientific research services; scientific laboratory services; scientific genetic testing for scientific research purposes; scientific advisory services relating to carbon offsetting; compilation of scientific information; preparation of scientific reports for scientific analysis purposes; scientific research and development; conducting of scientific studies in the field of medicine; providing laboratory research services featuring the conducting of scientific experiments relating to pharmaceuticals; scientific research relating to bacteriology; scientific research relating to biology; scientific research in the field of genetics and genetic engineering; design and development of diagnostic apparatus; research and development in the field of diagnostic preparations; biotechnology testing relating to DNAfor scientific research purposes; microbiological testing for scientific research purposes; bacteriological research and testing for scientific research purposes; analytical services relating to the testing of the bacterial content of liquids for scientific research purposes; medical testing for research purposes
Class 44
Rental of apparatus and installations in the field of medical technologyrental of medical equipment; consultancy services in the fields of medical and orthopedic surgery; medical diagnostic testingmonitoring and reporting services; surgical diagnostic services in the nature of exploratory surgery services for use in diagnosing medical illness and conditions; medical testing for diagnostic and treatment purposesmedical services for the testing of blood; medical services for the testing of sera; medical and healthcare services in the fields of DNAgenetics and genetic testing; medical testing services relating to the diagnosis and treatment of disease
Publications
History of USPTO decisions and trademark events.
66 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/20/2021
PUBO
PUBLISHED FOR OPPOSITION
04/20/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/31/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/15/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/08/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
03/08/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/08/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
03/08/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/08/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/08/2021
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/23/2021
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
12/29/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/14/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
12/03/2020
ALIE
ASSIGNED TO LIE
12/03/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/03/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
12/03/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/03/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/03/2020
OTHE
CASE RETURNED TO EXAMINATION
12/03/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
12/03/2020
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
11/24/2020
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
11/24/2020
APET
ASSIGNED TO PETITION STAFF
11/24/2020
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
09/30/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/22/2020
EX5G
SOU EXTENSION 5 GRANTED
07/21/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/21/2020
EXT5
SOU EXTENSION 5 FILED
07/01/2020
EEXT
SOU TEAS EXTENSION RECEIVED
07/01/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/01/2020
EX4G
SOU EXTENSION 4 GRANTED
01/30/2020
EXT4
SOU EXTENSION 4 FILED
01/30/2020
EEXT
SOU TEAS EXTENSION RECEIVED
01/30/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/13/2019
EX3G
SOU EXTENSION 3 GRANTED
07/11/2019
EXT3
SOU EXTENSION 3 FILED
07/11/2019
EEXT
SOU TEAS EXTENSION RECEIVED
07/11/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/02/2019
EX2G
SOU EXTENSION 2 GRANTED
01/31/2019
EXT2
SOU EXTENSION 2 FILED
01/31/2019
EEXT
SOU TEAS EXTENSION RECEIVED
01/31/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/03/2018
EX1G
SOU EXTENSION 1 GRANTED
06/29/2018
EXT1
SOU EXTENSION 1 FILED
06/29/2018
EEXT
SOU TEAS EXTENSION RECEIVED
06/29/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/06/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/12/2017
PUBO
PUBLISHED FOR OPPOSITION
12/12/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/22/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/04/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/30/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/30/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/26/2017
GNRT
NON-FINAL ACTION E-MAILED
06/26/2017
CNRT
NON-FINAL ACTION WRITTEN
06/26/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/25/2017
GNRT
NON-FINAL ACTION E-MAILED
06/25/2017
CNRT
NON-FINAL ACTION WRITTEN
06/25/2017
DOCK
ASSIGNED TO EXAMINER
06/22/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/06/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/05/2017
NWAP
NEW APPLICATION ENTERED
04/03/2017
Continuous trademark protection
Get notified about every new filing that threatens Q or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.